VIVO Ventures Vii, LLC, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), sold 1,815,656 shares at $22.72 ($41.8M) on 2016-11-18, disclosed to the SEC on 2016-11-18.
Open-market sale of $41.8M ACRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.25 | 448,063 | $10.4M | 24.9% |
| 2 | $23.25 | 448,063 | $10.4M | 24.9% |
| 3 | $27.30 | 9,765 | $267K | 0.6% |
| 4 | $27.30 | 9,765 | $267K | 0.6% |
| 5 | $22.72 | 440,402 | $10.0M | 23.9% |
| 6 | $22.72 | 9,598 |
| $218K |
| 0.5% |
| 7 | $22.72 | 9,598 | $218K | 0.5% |
| 8 | $22.72 | 440,402 | $10.0M | 23.9% |
| Total | $23.03 avg | 1,815,656 | $41.8M | 100% |
| Filing → |
| CDXS | SELL | 2016-08-05 | $549K | — | Filing → |
| MEIP | SELL | 2015-11-09 | $720K | — | Filing → |
| ACRS | BUY | 2015-10-13 | $5.0M | — | Filing → |